After achieving a landmark settlement, in which the negligent defendants have agreed to fund immunotherapy for a claimant who has developed cancer, Michael Rawlinson QC examines the dilemma of the prospect and effect of immunotherapy in a recent blog post.
The full blog post can be found here.
Kings Technology and Construction Series Construction Law Update
Have We Got Planning News for You: S2 Ep10 with Andy Street CBE
On the Ball: The Rugby Union Conference
© Copyright 2020 Kings Chambers. All rights reserved.
Continue using site